229 related articles for article (PubMed ID: 3818148)
1. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
[TBL] [Abstract][Full Text] [Related]
2. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
3. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Londong W; Londong V; Prechtl R; Weber T; von Werder K
Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
[TBL] [Abstract][Full Text] [Related]
4. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Bianchi Porro G
Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
[TBL] [Abstract][Full Text] [Related]
5. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
Giacosa A; Cheli R; Molinari F; Parodi MC
Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease.
Mahachai V; Reilly P; Thomson AB
Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132
[TBL] [Abstract][Full Text] [Related]
7. Effect of ranitidine on the content of glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
Scand J Gastroenterol; 1984 Jul; 19(5):650-4. PubMed ID: 6089304
[TBL] [Abstract][Full Text] [Related]
8. Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.
Lazzaroni M; Sangaletti O; Del Soldato P; Bianchi Porro G
Digestion; 1985; 32(4):267-72. PubMed ID: 3840755
[TBL] [Abstract][Full Text] [Related]
9. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
[TBL] [Abstract][Full Text] [Related]
10. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
Londong W; Londong V; Ruthe C; Weizert P
Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
[TBL] [Abstract][Full Text] [Related]
11. Prolonged influence of a meal on the effect of ranitidine.
Frislid K; Berstad A
Scand J Gastroenterol; 1984 May; 19(3):429-32. PubMed ID: 6330872
[TBL] [Abstract][Full Text] [Related]
12. The effect of pirenzepine on meal-stimulated gastric acid secretion, gastrin release and gastric emptying.
Bianchi Porro G; Prada A; Parente F; Sangaletti O; Lazzaroni M
Scand J Gastroenterol Suppl; 1982; 72():159-62. PubMed ID: 6957983
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
Ippoliti AF; Isenberg JI; Hagie L
Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
[TBL] [Abstract][Full Text] [Related]
14. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
Thomas FJ; Koss MA; Hogan DL; Isenberg JI
Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
[TBL] [Abstract][Full Text] [Related]
15. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
Mahachai V; Walker K; Pinchbeck B; Thomson AB
Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
[TBL] [Abstract][Full Text] [Related]
16. Carprofen and the therapy of gastroduodenal ulcerations by ranitidine.
Czarnobilski Z; Bem S; Czarnobilski K; Konturek SJ
Hepatogastroenterology; 1985 Feb; 32(1):20-3. PubMed ID: 3872836
[TBL] [Abstract][Full Text] [Related]
17. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients.
Ippoliti AF; Isenberg JI; Maxwell V; Walsh JH
Gastroenterology; 1976 Apr; 70(4):488-91. PubMed ID: 1254135
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
de Gara CJ; Burget DW; Silletti C; Hunt RH
Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
[TBL] [Abstract][Full Text] [Related]
19. Effect of pirenzepine on meal-stimulated acid secretion and gastrin release in normal man.
Mignon M; Vatier J; Bauer P; Bonfils S
Scand J Gastroenterol Suppl; 1982; 72():145-51. PubMed ID: 6753112
[TBL] [Abstract][Full Text] [Related]
20. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
